Canada markets closed

Cosmo Pharmaceuticals N.V. (C43.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
76.00+1.00 (+1.33%)
At close: 05:17PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 1.23B
Enterprise Value 1.18B
Trailing P/E 112.78
Forward P/E 10.54
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)11.68
Price/Book (mrq)2.79
Enterprise Value/Revenue 11.34
Enterprise Value/EBITDA 28.06

Trading Information

Stock Price History

Beta (5Y Monthly) 1.19
52-Week Change 338.89%
S&P500 52-Week Change 325.01%
52 Week High 377.00
52 Week Low 335.00
50-Day Moving Average 369.16
200-Day Moving Average 353.24

Share Statistics

Avg Vol (3 month) 337
Avg Vol (10 day) 318
Shares Outstanding 516.05M
Implied Shares Outstanding 616.38M
Float 88.49M
% Held by Insiders 147.15%
% Held by Institutions 110.01%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 42
Forward Annual Dividend Yield 42.67%
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 32.67%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4157.89%
Dividend Date 3N/A
Ex-Dividend Date 4May 28, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 1.19%
Operating Margin (ttm)9.62%

Management Effectiveness

Return on Assets (ttm)1.16%
Return on Equity (ttm)0.30%

Income Statement

Revenue (ttm)96.72M
Revenue Per Share (ttm)6.01
Quarterly Revenue Growth (yoy)-12.40%
Gross Profit (ttm)N/A
EBITDA 25.78M
Net Income Avi to Common (ttm)1.15M
Diluted EPS (ttm)0.67
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)50.27M
Total Cash Per Share (mrq)3.13
Total Debt (mrq)1.84M
Total Debt/Equity (mrq)0.42%
Current Ratio (mrq)4.41
Book Value Per Share (mrq)26.58

Cash Flow Statement

Operating Cash Flow (ttm)33.62M
Levered Free Cash Flow (ttm)15.96M